Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0ET80 | ISIN: ZAE000066692 | Ticker: LDZA
Tradegate
17.11.26 | 17:09
9,250 Euro
-1,07 % -0,100
Branche
Pharma
Aktienmarkt
AFRIKA
1-Jahres-Chart
ASPEN PHARMACARE HOLDINGS LIMITED Chart 1 Jahr
5-Tage-Chart
ASPEN PHARMACARE HOLDINGS LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
9,2009,45018.11.
9,2009,45018.11.

Aktuelle News zur ASPEN PHARMACARE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.11.ASPEN PHARMACARE HOLDINGS LIMITED - Regulatory Approvals for Aspens Generic Injectable Semaglutide in Brazil and South Africa2
10.11.ASPEN PHARMACARE HOLDINGS LIMITED - Notification in terms of Section 122 (3)(b) of the Companies Act and Section 6.54 of the JSE Listings Requirements1
10.11.ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by a Director, Prescribed Officer and the Company Secretary of Aspen and the Company Secretary of a Major Subsidiary of Aspen1
09.11.ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by a Prescribed Officer2
09.11.ASPEN PHARMACARE HOLDINGS LIMITED - Grant and Acceptance of Share Awards by Directors, Prescribed Officers and The Company Secretary of Aspen and a Director and the Company Secretary of a Major Subsidiary of Aspen2
09.11.ASPEN PHARMACARE HOLDINGS LIMITED - Vesting of Share Awards of Directors, Prescribed Officers and the Company Secretary of Aspen and a Director and the Company Secretary of a Major Subsidiary of Aspen2
ASPEN PHARMACARE Aktie jetzt für 0€ handeln
05.11.ASPEN PHARMACARE HOLDINGS LIMITED - General Repurchase of Ordinary Shares: Subsequent 3% Repurchase1
05.11.ASPEN PHARMACARE HOLDINGS LIMITED - Update on the Divestment of a Womens Health Product in Europe to Ennogen1
02.11.ASPEN PHARMACARE HOLDINGS LIMITED - Divestment of a Womens Health Product in Europe to Ennogen4
23.10.ASPEN PHARMACARE HOLDINGS LIMITED - Availability of Integrated Reporting Suite, B-BBEE Verification Certificate and Further Notice of Annual General Meeting1
02.10.ASPEN PHARMACARE HOLDINGS LIMITED - No Change Statement, Availability of Audited Annual Financial Statements and Notice of Annual General Meeting1
03.09.Earnings Call: Aspen Pharmacare hebt Gewinnprognose für GJ 2026 an und stellt starkes Wachstum für 2027 in Aussicht5
02.09.Aspen Pharmacare Holdings EPS of 596.00 cents, revenue of R34.8B1
02.09.ASPEN PHARMACARE HOLDINGS LIMITED - Reviewed Condensed Group Financial Results for the year ended 30 June 2026 and Cash Dividend Declaration1
02.09.ASPEN PHARMACARE HOLDINGS LIMITED - General repurchase of ordinary shares1
21.08.ASPEN PHARMACARE HOLDINGS LIMITED - Business update and trading statement for the year ended 30 June 20261
03.08.ASPEN PHARMACARE HOLDINGS LIMITED - Notice regarding the Release of Aspens Financial Results for the year ending 30 June 2026, and Results Presentation2
20.07.Aspen Pharmacare erhält Zulassung für Ozempic-Generikum in Kanada30
20.07.ASPEN PHARMACARE HOLDINGS LIMITED - Health Canada approves Aspen-Semaglutide2
09.07.ASPEN PHARMACARE HOLDINGS LIMITED - Proposed Succession and Board Composition Update1
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1